Neuronetics (STIM) Tops Q4 EPS by 3c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. JBHT
3. CRWV
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. USB
10. SPY

Go back to Neuronetics (STIM) Tops Q4 EPS by 3c, Revenues Beat

Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

March 3, 2020 6:01 AM EST

MALVERN, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the fourth quarter and full year of 2019.

Fourth Quarter 2019 Highlights

Fourth quarter 2019 revenue of $17.4 million, an increase of 11% over the fourth quarter of 2018Fourth quarter 2019 U.S. treatment session revenue of $11.2 million, an increase of 13% over the... More